{"data":[{"accessionNo":"0000919574-26-002913","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"Heron Therapeutics, Inc.","ticker":"HRTX","cusip":"427746102","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000919574-26-002913","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"Heron Therapeutics, Inc.","ticker":"HRTX","cusip":"427746102","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000919574-26-002913","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"Heron Therapeutics, Inc.","ticker":"HRTX","cusip":"427746102","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000102909-26-001421","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"Heron Therapeutics Inc","ticker":"HRTX","cusip":"427746102","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Clearline Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":12235239,"percentOfClass":6.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Clearline Capital LLC","reportingCik":null,"personType":"HC","sharesOwned":12235239,"percentOfClass":6.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Marc Majzner","reportingCik":null,"personType":"HC,IN","sharesOwned":12235239,"percentOfClass":6.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000102909-26-000207","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000818033","issuerName":"Heron Therapeutics Inc","ticker":"HRTX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":9820384,"percentOfClass":5.35,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-25-000011","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Clearline Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":9712527,"percentOfClass":5.3,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-25-000011","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Clearline Capital LLC","reportingCik":null,"personType":"HC","sharesOwned":9712527,"percentOfClass":5.3,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0001600136-25-000011","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Marc Majzner","reportingCik":null,"personType":"IN,HC","sharesOwned":9712527,"percentOfClass":5.3,"filedAt":"2025-11-26","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000102909-25-000136","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0000818033","issuerName":"Heron Therapeutics Inc","ticker":"HRTX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":8459784,"percentOfClass":4.61,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000902664-25-004460","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-10-15","reportingPerson":"Rubric Capital Management LP","reportingCik":"0001687509","personType":"IA,OO","sharesOwned":30046828,"percentOfClass":15.9,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"},{"accessionNo":"0000902664-25-004460","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0000818033","issuerName":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-10-15","reportingPerson":"David Rosen","reportingCik":"0001898677","personType":"IN,HC","sharesOwned":30046828,"percentOfClass":15.9,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx"}],"updatedAt":"2026-11-03T13:36:46.988Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/hrtx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}